Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil

Assis, Tália Santana Machado de; Rabello, Ana; Cota, Gláucia; Werneck, Guilherme Loureiro; Azeredo-da-Silva, André Luís Ferreira de.
Rev. Soc. Bras. Med. Trop ; 52: e20180272, 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1041550

Documentos relacionados

  1. Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil.
  2. Treatment for human visceral leishmaniasis: a cost-effectiveness analysis for Brazil.
  3. The direct costs of treating human visceral leishmaniasis in Brazil.
  4. Drug regimens for visceral leishmaniasis in Mediterranean countries.
  5. Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
  6. Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India.
  7. Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
  8. Amphotericin B therapy in children with visceral leishmaniasis: daily vs. alternate day, a randomized trial.
  9. The direct costs of treating human visceral leishmaniasis in Brazil
  10. A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study.